Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find out various ways to monetize your website and turn your traffic into revenue. Start maximizing your online earnings today!
17,574 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A man breached the Mar-a-Lago perimeter and was killed in a confrontation with Secret Service and a local deputy. The...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...
As Seer gears up for 2025 earnings, investors weigh growth, margins, and risk. This guide breaks down the drivers beh...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
Former President Trump floated easing oil sanctions and hinted the Iran conflict could wrap up soon, sending ripples ...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
A massive wave of AI investment is reshaping markets. Learn how three top tech stocks could ride the $700 billion spe...
As 2025 earnings season hits, savvy investors need a clear playbook for cibus (cbus) 2025 earnings. This guide breaks...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
New SSA data shows benefits rise with age, peaking after delaying retirement credits. But even at 70, many retireesSt...